BioAtla BCAB
NASDAQ BCAB
$3.18 +0.00 (+0.00%)
As of: Aug 21, 2026 · 3:59 PM EDT

BioAtla (BCAB) Other Non Operating Income (2020 - 2026)

BioAtla (BCAB) posted quarterly Other Non Operating Income of $3.0 million for Q1 2026, up 30.0% year-over-year from $2.3 million in Q1 2025, and up 660.3% quarter-over-quarter from -$529000.0 in Q4 2025.

BioAtla (BCAB) Other Non Operating Income (2020 - 2026) Analysis & Trends

BioAtla's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.

  • In Q1 2026, Other Non Operating Income rose 30.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $382000.0 (down 92.69% YoY), while the FY2025 annual figure was -$302000.0, down 107.25% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $3.0 million, up from -$529000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $3.0 million in Q1 2026, with the low at -$2.0 million in Q3 2025.
  • The 5-year median for Other Non Operating Income is $1.0 million (2022), against an average of $865411.8.
  • The sharpest annual moves came in 2023 and 2025: Other Non Operating Income soared 1497.83% in 2023, then plunged 390.79% in 2025.
  • BioAtla's Other Non Operating Income stood at $1.0 million in 2022, then surged by 58.41% to $1.6 million in 2023, then slipped by 15.58% to $1.4 million in 2024, then tumbled by 138.9% to -$529000.0 in 2025, then surged by 660.3% to $3.0 million in 2026.
  • Business Quant data shows BCAB's Other Non Operating Income at $3.0 million in Q1 2026, -$529000.0 in Q4 2025, and -$2.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 BioAtla 5.41 Mn 5.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 225,000.00
Mar 31, 2026 2.96 Mn
Dec 31, 2025 -529,000.00
Sep 30, 2025 -1.99 Mn
Jun 30, 2025 -64,000.00
Mar 31, 2025 2.28 Mn
Dec 31, 2024 1.36 Mn
Sep 30, 2024 684,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 1.22 Mn
Dec 31, 2023 1.61 Mn
Sep 30, 2023 1.70 Mn
Jun 30, 2023 1.45 Mn
Mar 31, 2023 1.47 Mn
Dec 31, 2022 1.02 Mn
Sep 30, 2022 400,000.00
Jun 30, 2022 149,000.00
Mar 31, 2022 92,000.00
Sep 30, 2021 765,000.00
Jun 30, 2021 79,000.00